作者
Satoshi Kawada, Praloy Chakraborty, Lisa Albertini, Abhishek Bhaskaran, Erwin N Oechslin, Candice Sliversides, Rachel M Wald, S Lucy Roche, Louise Harris, Lorna Swan, Rafael Alonso-Gonzalez, Sara Thorne, Eugene Downar, Kumaraswamy Nanthakumar, Blandine Mondésert, Paul Khairy, Krishnakumar Nair
发表日期
2021/3/1
期刊
Canadian Journal of Cardiology
卷号
37
期号
3
页码范围
407-416
出版商
Elsevier
简介
Background
Implantable cardioverter-defibrillators (ICDs) have been proven to prevent sudden cardiac death in adult congenital heart disease (ACHD) patients. Although the left side is chosen by default, implantation from the right side is often required. However, little is known about the efficacy and safety of right-sided ICDs in ACHD patients.
Methods
In this study we reviewed a total of 191 ACHD patients undergoing ICD/cardioverter resynchronisation therapy-defibrillator (CRT-D) implantation at our hospital between 2001 and 2019 (134 men and 57 women; age [mean ± standard deviation], 41.5 ± 14.8 years).
Results
Twenty-seven patients (14.1%) had right-sided devices. The most common causes of right-sided implantation were persistent left superior vena cava and vein occlusion (37.0%). Although procedure time (202.8 ± 60.5 minutes vs 143.8 ± 69.1 minutes, P = 0.008) was longer and the procedural success …
引用总数